Literature DB >> 20691696

Neutrophil activation during transmigration in vivo and in vitro A translational study using the skin chamber model.

Josefin M Paulsson1, Stefan H Jacobson, Joachim Lundahl.   

Abstract

Neutrophil transmigration can be studied in vitro by use of the transwell model and in vivo by the skin chamber model. Activation during transmigration involves translocation of secretory vesicles and granules to the plasma- and phagolysosome membranes. In this study, we compared the skin chamber model with the transwell model, focusing on the mobilization of CR1 (CD35), CR3 (CD11b/CD18) and CD63 from intracellular vesicles and granules. In addition, functional responses towards a bacterial related stimulus, formyl-methionyl-leucyl-phenylalanine (fMLP), in terms of CR3 expression and production of reactive oxygen species (ROS) were assessed. Discrepancies between the skin chamber model and the transwell model were observed. The expression of CR1 increased following in vivo transmigration (p<0.001) and, in contrast, decreased following in vitro transmigration (p=0.004). Furthermore, CR1 was mobilized following an isolation procedure included in the transwell model. The expression of CR3 increased following both in vivo (p<0.001) and in vitro (p=0.03) transmigration. However, in vitro transmigration did not influence the fMLP induced CR3 expression which was significantly increased following in vivo transmigration (p=0.01). In addition, the fMLP induced production of ROS was significantly reduced following in vitro transmigration (p=0.002) but unaltered after in vivo transmigration, indicating differences between the impact of the two systems on cellular activation. The observed discrepancies between the two models might be partly explained by granule mobilization and neutrophil priming, induced during the isolation procedure included in the transwell model, which results in an altered cellular activation. Therefore, mobilization of granules needs to be accounted for when interpreting data from different model systems.
Copyright © 2010 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20691696     DOI: 10.1016/j.jim.2010.07.015

Source DB:  PubMed          Journal:  J Immunol Methods        ISSN: 0022-1759            Impact factor:   2.303


  9 in total

1.  Neutrophil-mediated anticancer drug delivery for suppression of postoperative malignant glioma recurrence.

Authors:  Jingwei Xue; Zekai Zhao; Lei Zhang; Lingjing Xue; Shiyang Shen; Yajing Wen; Zhuoyuan Wei; Lu Wang; Lingyi Kong; Hongbin Sun; Qineng Ping; Ran Mo; Can Zhang
Journal:  Nat Nanotechnol       Date:  2017-06-19       Impact factor: 39.213

2.  Regulation of neutrophil apoptosis differs after in vivo transmigration to skin chambers and synovial fluid: a role for inflammasome-dependent interleukin-1β release.

Authors:  Karin Christenson; Lena Björkman; Anna Karlsson; Johan Bylund
Journal:  J Innate Immun       Date:  2013-04-05       Impact factor: 7.349

3.  Real-time imaging of endothelial cell-cell junctions during neutrophil transmigration under physiological flow.

Authors:  Jeffrey Kroon; Anna E Daniel; Mark Hoogenboezem; Jaap D van Buul
Journal:  J Vis Exp       Date:  2014-08-14       Impact factor: 1.355

Review 4.  Multiple Phenotypic Changes Define Neutrophil Priming.

Authors:  Irina Miralda; Silvia M Uriarte; Kenneth R McLeish
Journal:  Front Cell Infect Microbiol       Date:  2017-05-29       Impact factor: 5.293

5.  Alteration in Leukocyte Subsets and Expressions of FcγR and Complement Receptors among Female Ragpickers in Eastern India.

Authors:  Nandan K Mondal; Shabana Siddique; Madhuchanda Banerjee; Sanghita Roychoudhury; Sayali Mukherjee; Mark S Slaughter; Twisha Lahiri; Manas R Ray
Journal:  Saf Health Work       Date:  2016-12-09

6.  Endothelial inflammation and neutrophil transmigration are modulated by extracellular matrix composition in an inflammation-on-a-chip model.

Authors:  Rebecca B Riddle; Karin Jennbacken; Kenny M Hansson; Matthew T Harper
Journal:  Sci Rep       Date:  2022-04-27       Impact factor: 4.996

7.  Neutrophil-mediated delivery of the combination of colistin and azithromycin for the treatment of bacterial infection.

Authors:  Jiacong Gao; Xueyan Hu; Congjuan Xu; Mingming Guo; Shouyi Li; Fan Yang; Xiaolei Pan; Fangyu Zhou; Yongxin Jin; Fang Bai; Zhihui Cheng; Zhenzhou Wu; Shuiping Chen; Xinglu Huang; Weihui Wu
Journal:  iScience       Date:  2022-08-30

8.  Acute Respiratory Distress Syndrome Neutrophils Have a Distinct Phenotype and Are Resistant to Phosphoinositide 3-Kinase Inhibition.

Authors:  Jatinder K Juss; David House; Augustin Amour; Malcolm Begg; Jurgen Herre; Daniel M L Storisteanu; Kim Hoenderdos; Glyn Bradley; Mark Lennon; Charlotte Summers; Edith M Hessel; Alison Condliffe; Edwin R Chilvers
Journal:  Am J Respir Crit Care Med       Date:  2016-10-15       Impact factor: 30.528

9.  Neutrophils Enable Local and Non-Invasive Liposome Delivery to Inflamed Skeletal Muscle and Ischemic Heart.

Authors:  Junyi Che; Adrian Najer; Anna K Blakney; Paul F McKay; Mohamed Bellahcene; Charles W Winter; Amalia Sintou; Jiaqing Tang; Timothy J Keane; Michael D Schneider; Robin J Shattock; Susanne Sattler; Molly M Stevens
Journal:  Adv Mater       Date:  2020-10-26       Impact factor: 32.086

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.